The U.S. Attorney General last week subpoenaed Johnson & Johnson’s Ortho-McNeil Pharmaceutical division for marketing documents for epilepsy drug Topomax. J&J said it is cooperating with the AG’s Boston office.
The Raritan, NJ-based company is waiting for U.S. regulators to approve Topomax to treat migraines, Reuters reports. The Food and Drug Administration earlier this year asked Ortho-McNeil to add warnings about hypothermia and oligohidrosis (decreased sweating) to Topomax labeling, per Reuters.
Network
